Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C32H31BrN2O2 |
| Molecular Weight | 555.505 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=NC2=CC=C(Br)C=C2C=C1[C@@H](C3=CC=CC=C3)[C@@](O)(CCN(C)C)C4=CC=CC5=CC=CC=C45
InChI
InChIKey=QUIJNHUBAXPXFS-XLJNKUFUSA-N
InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
589917
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
NDF-RT |
N0000186775
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
WHO-VATC |
QJ04AK05
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
WHO-ATC |
J04AK05
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
199304
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
||
|
LIVERTOX |
NBK548859
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL376488
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
XX-135
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
100000126166
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
78846I289Y
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
m2288
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID80903989
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
Bedaquiline
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
SUB32824
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
DB08903
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
5388906
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
4741
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
C87658
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
1364504
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | RxNorm | ||
|
8217
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
EU/3/05/314 POSITIVE
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | On 26 August 2005, orphan designation (EU/3/05/314) was granted by the European Commission to Tibotec Pharmaceuticals Ltd., Ireland, for (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol for the treatment of tuberculosis. | ||
|
Bedaquiline
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
72292
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
N0000186774
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | Diarylquinolines [Chemical/Ingredient] | ||
|
9316
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
843663-66-1
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
78846I289Y
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY | |||
|
C493870
Created by
admin on Fri Dec 15 16:23:58 UTC 2023 , Edited by admin on Fri Dec 15 16:23:58 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE LESS ACTIVE (PARENT)
SALT/SOLVATE (PARENT)
